DISRUPT brings together multidisciplinary teams from four New York City institutions, Mount Sinai’s Tisch Cancer Institute (TCI), Columbia’s Herbert Irving Comprehensive Cancer Center (HICCC), Montefiore Einstein Cancer Center (MECC) and The City College of New York (CCNY).
These cancer centers are charged with reducing cancer disparities that affect approximately two million people residing in some of the most diverse and underserved communities in the United States.
Dr. Nina Bickell
Nina Bickell, MD, MPH, has spent the past 20 years focusing on underlying reasons for disparities in the quality of cancer care many BIPOC patients get and designing different approaches to improve their cancer care. Dr. Bickell is a member of the senior leadership team at The Tisch Cancer Institute (TCI).
Dr. Grace Hillyer
Dr. Hillyer’s expertise lies in the applied use of behavioral theory to investigate multilevel
psychological, social, and cultural factors impacting health behavior among underrepresented
and underserved populations and the application of mixed research methodology to construct
and implement tailored educational interventions.
Mary Beth Terry
Mary Beth Terry, PhD, focuses her research on environmental modifiers of cancer risk. She is the Director of Community Outreach and Engagement with the Herbert Irving Comprehensive Cancer Center at Columbia University Irving Medical Center. She has spent over 20 years leading studies of cancer risk reduction in local communities and around the world.
Dr. Parisa Tehranifar
Parisa Tehranifar, DrPH is a cancer epidemiologist and health disparities researcher. Her research focuses on improving the implementation of breast cancer screening and prevention in racially and ethnically diverse, immigrant and underserved communities.